We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
ALFAXALONE SEDATION FOR CENTRAL VENOUS CATHETERIZATION IN A DOG UNDERGOING HEMODIALYSIS: CASE REPORT.
- Authors
FLOREA, Cristian Ionuț; BOANCĂ, Crina Alexandra; RĂDULESCU, Andrei; ȘTEFĂNESCU, Alina; VIȚĂLARU, Alexandru Bogdan
- Abstract
A 5 years old Shar Pei female, diagnosed with acute kidney injury was referred for hemodialysis therapy. The dog was presented with lethargy, lack of appetite, severe weight loss, dehydration (7-10%) and pale mucous membranes. To prevent exacerbation of preexisting comorbidities, in order to sedate a renal patient, a safe anesthesia protocol requires understanding the kidney disease pathology and hemodialysis therapy implications. A central venous catheter (CVC) was placed under a light sedation with additional oxygen therapy. Sedation was induced intravenously with alfaxalone (Alfaxan® multidose), on a peripheral catheter. The dose was titrated until full relaxation of the patient was observed. During the procedure, there were no major hemodynamics changes in the patient. Alfaxalone is a shortacting and rapid duration anesthetic with minimal or no cardiovascular consequences. When given titrated to effect, it represents the best choice for short sedation in central venous catheterization for acute renal patients undergoing hemodialysis.
- Subjects
CENTRAL venous catheters; PATHOLOGY; ACUTE kidney failure; MUCOUS membranes; OXYGEN therapy; ANIMAL sedation
- Publication
Scientific Works. Series C, Veterinary Medicine, 2024, Vol 70, Issue 1, p82
- ISSN
2065-1295
- Publication type
Case Study